Results 191 to 200 of about 1,581,145 (310)

Chlorella vulgaris biorefineries: sustainable biofuels and high‐value carbon capture

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Global reliance on fossil fuels has created urgent economic and environmental challenges, yet large‐scale use of algal biomass remains limited by production costs. Industrial scaling is constrained by inefficient harvesting and the technical challenges of processing recalcitrant cell walls.
Sandyelle Ferreira Alcântara Araújo, Antonio Átila Menezes Ferreira, Lucia Andrea Sindeaux de Oliveira, Dayana Nascimento Dari, Devany Quintela Soares, Eliana Elisa Francelino Mavie, Francisco Leonardo Alves de Moraes Sousa, Jessica Lopes da Silva, João Vitor Gomes de Araújo Silva, Thiago Queiroz da Silva, Ana Karine Portela Vasconcelos, Kelma Maria dos Santos Pires Cavalcante, John Hebert da Silva Felix, José Cleiton Sousa dos Santos   +13 more
wiley   +1 more source

Crisis-driven innovation in the Republic of Korea's in vitro diagnostics industry: a pandemic case study. [PDF]

Osong Public Health Res Perspect
Kim M, Jeong H, Shin K.
europepmc   +1 more source

Simulating competition in the US bioeconomy to produce hard‐to‐electrify transportation fuels using limited biomass resources

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract This study presents a novel bioeconomy optimization framework, BiOpt, designed to address critical questions regarding the strategic use of limited US biomass resources for biofuel production. By integrating detailed techno‐economic analyses, life cycle assessments, and resource assessment data, BiOpt optimizes resource distributions across ...
Nicholas A. Carlson, Emily K. Newes, Kristen Lu, Eric C. D. Tan   +3 more
wiley   +1 more source

Public contributions to the development of antibiotics: two successful and two failed investments. [PDF]

J Pharm Policy Pract
Schmidt L, Sehic O, Theuretzbacher U, Wild C.   +3 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Global Perspectives in Plastic Surgery: View of Plastic Surgeons From Ecuador. [PDF]

Plast Reconstr Surg Glob Open
Rai P, Álvarez E, Gosain AK.
europepmc   +1 more source

Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Introduction Introduction Reporting adverse drug reactions (ADRs) is essential for detecting drug risks. Despite legal obligations in Switzerland, underreporting remains an issue. This study assessed practice, knowledge and attitudes towards the spontaneous ADR reporting system among physicians and pharmacists.
Fiona A. Strobel, Thomas Stammschulte, Patrick E. Beeler   +2 more
wiley   +1 more source

Social impact bonds: opportunities for funding health promotion and disease prevention. [PDF]

BMC Public Health
Plankó S, Hulse E, Rutten-van Mölken M, Goossens L, Wordsworth S, Koleva-Kolarova R, Tsiachristas A, Wright S, Zemplényiné Bartha J, Nagy B, Babarczy B.   +10 more
europepmc   +1 more source

Applying a panel network formation model to limited partnership matching in the private capital market. [PDF]

Soc Netw Anal Min
Shang Y, Leifeld P.
europepmc   +1 more source

Promotion of private investment [PDF]

Intereconomics, 1969
openaire   +2 more sources